{"id":"eprinomectin","rwe":[{"pmid":"41819959","year":"2026","title":"Anthelmintic resistance on meat goat properties in Queensland and New South Wales, Australia, with a comparison of statistical methods.","finding":"","journal":"Veterinary parasitology, regional studies and reports","studyType":"Clinical Study"},{"pmid":"41694419","year":"2026","title":"Inherent P-glycoprotein deficiency and macrocyclic lactone toxicity in an Australian Maine Coon cat homozygous for ABCB11930_1931del TC.","finding":"","journal":"JFMS open reports","studyType":"Clinical Study"},{"pmid":"41649496","year":"2026","title":"Treatment of chorioptic mange in dairy cows contributes to improved animal welfare.","finding":"","journal":"Acta veterinaria Hungarica","studyType":"Clinical Study"},{"pmid":"41598995","year":"2025","title":"Prevalence of Lungworm Infections in Hedgehogs (Erinaceus roumanicus) in Greece and a Novel Therapeutic Approach for Treatment.","finding":"","journal":"Pathogens (Basel, Switzerland)","studyType":"Clinical Study"},{"pmid":"41560761","year":"2026","title":"Effectiveness of eprinomectin, albendazole and their combination therapy against strongyle nematode in dairy goats: A clinical field study using nemabiome-integrated approach in Thailand.","finding":"","journal":"Current research in parasitology & vector-borne diseases","studyType":"Clinical Study"}],"tags":[{"label":"Peptide","category":"modality"},{"label":"Active","category":"status"},{"label":"Anthelmintics","category":"pharmacology"},{"label":"Anti-Infective Agents","category":"pharmacology"},{"label":"Antiparasitic Agents","category":"pharmacology"},{"label":"Insecticides","category":"pharmacology"},{"label":"Pesticides","category":"pharmacology"}],"phase":"marketed","safety":{},"trials":[],"aliases":[],"patents":[],"pricing":[],"_sources":{"trials":{"url":"https://clinicaltrials.gov/search?intr=EPRINOMECTIN","method":"api_direct","source":"ClinicalTrials.gov","rawText":"","confidence":1,"sourceType":"ctgov","retrievedAt":"2026-04-20T00:57:36.116625+00:00"},"aiSummary":{"url":"","method":"ai_extraction","source":"AI Strategic Summary","aiModel":"featherless","rawText":"","confidence":0.9,"sourceType":"ai_extraction","retrievedAt":"2026-04-20T00:57:53.173699+00:00"},"regulatory.ca":{"url":"","method":"api_direct","source":"Health Canada DPD","rawText":"","confidence":1,"sourceType":"health_canada_dpd","retrievedAt":"2026-04-20T00:57:41.436299+00:00"},"publicationCount":{"url":"https://pubmed.ncbi.nlm.nih.gov/?term=EPRINOMECTIN","method":"api_direct","source":"PubMed/NCBI","rawText":"","confidence":1,"sourceType":"pubmed","retrievedAt":"2026-04-20T00:57:41.772573+00:00"},"crossReferences.chemblId":{"url":"https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL3989594/","method":"api_direct","source":"ChEMBL (EMBL-EBI)","rawText":"","confidence":1,"sourceType":"chembl","retrievedAt":"2026-04-20T00:57:42.491226+00:00"}},"allNames":"eprinex","offLabel":[],"synonyms":["eprinomectin","eprinex","MK-397"],"timeline":[],"aiSummary":"Eprinomectin (Eprinex) is a marketed antiparasitic drug that binds to glutamate-gated chloride channels on parasite nerve cells, leading to paralysis and death. A key strength is its unique mechanism of action, which differentiates it in the market. The primary risk is the key composition patent expiry in 2028, which could lead to increased competition from generics.","approvals":[{"date":"","orphan":false,"company":"","regulator":"FDA"}],"brandName":"Eprinex","ecosystem":[],"mechanism":{"modality":"Peptide","explanation":"","oneSentence":"","technicalDetail":"Eprinex binds to the glutamate-gated chloride channels on the surface of parasite nerve cells, causing an influx of chloride ions and hyperpolarization of the cell membrane, leading to paralysis and death."},"commercial":{},"references":[{"id":1,"url":"https://drugcentral.org/drugcard/5533","fields":["approvals","synonyms","ATC","PK","indications","contraindications","DDIs","targets","patents","FAERS"],"source":"DrugCentral"},{"id":2,"url":"https://pubmed.ncbi.nlm.nih.gov/?term=EPRINOMECTIN","fields":["publications"],"source":"PubMed/NCBI"}],"_enrichedAt":"2026-03-30T10:59:43.085591","_validation":{"fieldsValidated":1,"lastValidatedAt":"2026-04-20T00:57:53.173797+00:00","fieldsConflicting":1,"overallConfidence":0.8},"biosimilars":[],"competitors":[],"genericName":"eprinomectin","indications":{"approved":[],"offLabel":[],"pipeline":[]},"drugCategory":"active","labelChanges":[],"relatedDrugs":[],"trialDetails":[],"genericFilers":[],"latestUpdates":[],"manufacturing":[],"crossReferences":{"NDDF":"017998","UNII":"75KP30FD8O","CHEBI":"CHEBI:82596","INN_ID":"7371","RXNORM":"1006619","UMLSCUI":"C0529813","chemblId":"CHEMBL3989594","ChEMBL_ID":"CHEMBL3989594","KEGG_DRUG":"D04037","DRUGBANK_ID":"DB11405","PUBCHEM_CID":"6450531","MESH_SUPPLEMENTAL_RECORD_UI":"C101434"},"formularyStatus":[],"_enricherVersion":"v2","developmentCodes":[],"ownershipHistory":[],"publicationCount":420,"therapeuticAreas":["Other"],"biosimilarFilings":[],"recentPublications":[{"date":"2026 Apr","pmid":"41819959","title":"Anthelmintic resistance on meat goat properties in Queensland and New South Wales, Australia, with a comparison of statistical methods.","journal":"Veterinary parasitology, regional studies and reports"},{"date":"2026 Jan-Jun","pmid":"41694419","title":"Inherent P-glycoprotein deficiency and macrocyclic lactone toxicity in an Australian Maine Coon cat homozygous for ABCB11930_1931del TC.","journal":"JFMS open reports"},{"date":"2026 Feb 6","pmid":"41649496","title":"Treatment of chorioptic mange in dairy cows contributes to improved animal welfare.","journal":"Acta veterinaria Hungarica"},{"date":"2025 Dec 21","pmid":"41598995","title":"Prevalence of Lungworm Infections in Hedgehogs (Erinaceus roumanicus) in Greece and a Novel Therapeutic Approach for Treatment.","journal":"Pathogens (Basel, Switzerland)"},{"date":"2026","pmid":"41560761","title":"Effectiveness of eprinomectin, albendazole and their combination therapy against strongyle nematode in dairy goats: A clinical field study using nemabiome-integrated approach in Thailand.","journal":"Current research in parasitology & vector-borne diseases"}],"companionDiagnostics":[],"genericManufacturerList":[],"status":"active","companyName":"","companyId":"","modality":"Peptide","firstApprovalDate":"","enrichmentLevel":3,"visitCount":1,"regulatoryByCountry":[{"country_code":"US","regulator":"FDA","status":"approved","approval_date":null,"mah":"","brand_name_local":null,"application_number":""},{"country_code":"CA","regulator":"Health Canada","status":"approved","approval_date":null,"mah":"","brand_name_local":"","application_number":""},{"country_code":"BR","regulator":"ANVISA","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"MX","regulator":"COFEPRIS","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"AR","regulator":"ANMAT","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"TR","regulator":"TITCK","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"IN","regulator":"CDSCO","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"TH","regulator":"FDA-TH","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"MY","regulator":"NPRA","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"PH","regulator":"FDA-PH","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"CO","regulator":"INVIMA","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"ZA","regulator":"SAHPRA","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"TW","regulator":"TFDA","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"HK","regulator":"DH","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"IL","regulator":"MOH","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"SG","regulator":"HSA","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"AE","regulator":"MOH","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"KR","regulator":"MFDS","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"AU","regulator":"TGA","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"GB","regulator":"MHRA","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null}],"trialStats":{"total":0,"withResults":0},"validation":{"fieldsValidated":1,"lastValidatedAt":"2026-04-20T00:57:53.173797+00:00","fieldsConflicting":1,"overallConfidence":0.8},"verificationStatus":"enriching","dataCompleteness":{"mechanism":false,"indications":false,"safety":false,"trials":false,"score":0}}